MediSpend acquired the target/assets from RLDatix in a merger on not available.
Deal value was 2500000000 Sector: Life Sciences; Location: Global.
On the acquirer side, not available advised, led by James Brownstein, Adrian Duncan, Ben Hai, Peter Banyai, James Lauerman, Adam Diouri, Sean Kramer, Vin Thorn, Anthony Antioch.
Generated by AI, original source from - Data is in progress
RLDatix advisor
Firm name is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises RLDatix on merger of its Life Sciences division with MediSpend | The Sponsor - The Sponsor